Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Results can vary, but many users start to see significant changes within two to three months of consistent use, in ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...